However, it is unclear whether tumor cells are able to release exosomal PD-L2, and the function and regulation of exosomal PD-L2 in antitumor immunity are unexplored and worthy of further investigations (Solinas et al., 2020). The gene discussed is PDCD1LG2; the disease is neoplasm.